TRAF2-mediated Lys63-linked ubiquitination of DUSP14/MKP6 is essential for its phosphatase activity

Cellular Signalling

Volumn 28, Issue 1, 2016, Pages 145-151

  Yang, Chia Yu ^a   Chiu, Li Li ^b   Tan, Tse Hua ^c,d,e  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

DUSP14 MKP6; T cell receptor signaling; TRAF2; Ubiquitination

Indexed keywords

DUAL SPECIFICITY PHOSPHATASE 6; LYSINE; LYSINE 63; PHOSPHATASE; SHORT HAIRPIN RNA; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; DUAL SPECIFICITY PHOSPHATASE; DUSP14 PROTEIN, HUMAN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE; STRESS ACTIVATED PROTEIN KINASE; UBIQUITIN;

ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; ENZYME ASSAY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MASS SPECTROMETRY; MOLECULAR DYNAMICS; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; RESIDUE ANALYSIS; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; UBIQUITINATION; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; PHOSPHORYLATION; T LYMPHOCYTE;

DUAL-SPECIFICITY PHOSPHATASES; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LYMPHOCYTE ACTIVATION; LYSINE; MAP KINASE KINASE KINASES; MITOGEN-ACTIVATED PROTEIN KINASE PHOSPHATASES; NF-KAPPA B; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; T-LYMPHOCYTES; TNF RECEPTOR-ASSOCIATED FACTOR 2; UBIQUITIN; UBIQUITINATION;

EID: 84973568951     PISSN: 08986568     EISSN: 18733913     Source Type: Journal    
DOI: 10.1016/j.cellsig.2015.10.017     Document Type: Article

References (19)

1. Welchman R.L., Gordon C., Mayer R.J. Ubiquitin and ubiquitin-like proteins as multifunctional signals. Nat. Rev. Mol. Cell Biol. 2005, 6(8):599-609.
2. Dikic I., Wakatsuki S., Walters K.J. Ubiquitin-binding domains - from structures to functions. Nat. Rev. Mol. Cell Biol. 2009, 10(10):659-671.
3. Malynn B.A., Ma A. Ubiquitin makes its mark on immune regulation. Immunity 2010, 33(6):843-852.
4. Yang W.L., Zhang X., Lin H.K. Emerging role of Lys-63 ubiquitination in protein kinase and phosphatase activation and cancer development. Oncogene 2010, 29(32):4493-4503.
5. Trotman L.C., Wang X., Alimonti A., Chen Z., Teruya-Feldstein J., Yang H., Pavletich N.P., Carver B.S., Cordon-Cardo C., Erdjument-Bromage H., et al. Ubiquitination regulates PTEN nuclear import and tumor suppression. Cell 2007, 128(1):141-156.
6. McConnell J.L., Watkins G.R., Soss S.E., Franz H.S., McCorvey L.R., Spiller B.W., Chazin W.J., Wadzinski B.E. Alpha4 is a ubiquitin-binding protein that regulates protein serine/threonine phosphatase 2A ubiquitination. Biochemistry 2010, 49(8):1713-1718.
7. De Schutter J., Guillabert A., Imbault V., Degraef C., Erneux C., Communi D., Pirson I. SHIP2 (SH2 domain-containing inositol phosphatase 2) SH2 domain negatively controls SHIP2 monoubiquitination in response to epidermal growth factor. J. Biol. Chem. 2009, 284(52):36062-36076.
8. Huang C.Y., Tan T.H. DUSPs, to MAP kinases and beyond. Cell Biosci. 2012, 2(1):24.
9. Jeffrey K.L., Camps M., Rommel C., Mackay C.R. Targeting dual-specificity phosphatases: manipulating MAP kinase signalling and immune responses. Nat. Rev. Drug Discov. 2007, 6(5):391-403.
10. Marti F., Krause A., Post N.H., Lyddane C., Dupont B., Sadelain M., King P.D. Negative-feedback regulation of CD28 costimulation by a novel mitogen-activated protein kinase phosphatase, MKP6. J. Immunol. 2001, 166(1):197-206.
11. Klinger S., Poussin C., Debril M.B., Dolci W., Halban P.A., Thorens B. Increasing GLP-1-induced β-cell proliferation by silencing the negative regulators of signaling cAMP response element modulator-α and DUSP14. Diabetes 2008, 57(3):584-593.
12. Zheng H., Li Q., Chen R., Zhang J., Ran Y., He X., Li S., Shu H.B. The dual-specificity phosphatase DUSP14 negatively regulates tumor necrosis factor- and interleukin-1-induced nuclear factor-κB activation by dephosphorylating the protein kinase TAK1. J. Biol. Chem. 2013, 288(2):819-825.
13. Yang C.Y., Li J.P., Chiu L.L., Lan J.L., Chen D.Y., Chuang H.C., Huang C.Y., Tan T.H. Dual-specificity phosphatase 14 (DUSP14/MKP6) negatively regulates TCR signaling by inhibiting TAB1 activation. J. Immunol. 2014, 192(4):1547-1557.
14. Jabara H., Laouini D., Tsitsikov E., Mizoguchi E., Bhan A., Castigli E., Dedeoglu F., Pivniouk V., Brodeur S., Geha R. The binding site for TRAF2 and TRAF3 but not for TRAF6 is essential for CD40-mediated immunoglobulin class switching. Immunity 2002, 17(3):265-276.
15. Lin Y.W., Yang J.L. Cooperation of ERK and SCFSkp2 for MKP-1 destruction provides a positive feedback regulation of proliferating signaling. J. Biol. Chem. 2006, 281(2):915-926.
16. Calvisi D.F., Pinna F., Meloni F., Ladu S., Pellegrino R., Sini M., Daino L., Simile M.M., De Miglio M.R., Virdis P., et al. Dual-specificity phosphatase 1 ubiquitination in extracellular signal-regulated kinase-mediated control of growth in human hepatocellular carcinoma. Cancer Res. 2008, 68(11):4192-4200.
17. Wertz I.E., Dixit V.M. Signaling to NF-κB: regulation by ubiquitination. Cold Spring Harb. Perspect. Biol. 2010, 2(3):a003350.
18. Sun L., Deng L., Ea C.K., Xia Z.P., Chen Z.J. The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes. Mol. Cell 2004, 14(3):289-301.
19. Alvarez S.E., Harikumar K.B., Hait N.C., Allegood J., Strub G.M., Kim E.Y., Maceyka M., Jiang H., Luo C., Kordula T., et al. Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2. Nature 2010, 465(7301):1084-1088.